AI pioneer Innoplexus and phytopharmaceutical company DrD are partnering toRead More
“I missed it when I didn’t have access anymore. Filters allow me to focus on exactly what I need. Concept search vs. plain text was very helpful.
Top Authors in an area was something I never envisioned could exist at the touch of a button”
A small molecule team,
US large pharma
Great technology and data
Having sufficient data and analytical capability is critical to being able to identify potential baseline biomarkers…
Indication Prioritization using Artificial Intelligence (AI) and Machine Learning (ML).
As Global Medical Advisor Oncology @ Boehringer Ingelheim – I have been assigned to lead a new project: “Indication Prioritization using Artificial Intelligence and Machine Learning.”
Innoplexus wins Horizon Interactive Gold Award for Curia App
2020 — Innoplexus AG has been honored with the Horizon Interactive Gold Award for Curia App. The recognition comes in the category of Non-Profit.Read More
Innoplexus wins Silver Edison Award for OntosightⓇ Explore
Frankfurt, Germany, March 26, 2020 — Innoplexus AG has been honored with the Silver Edison Award 2020 for its proprietary OntosightⓇ Explore platform. The recognition comes in the category of Artificial Intelligence & User Experience. The finalists of the Edison Awards were announced on February 11th, 2020.Read More
TiE Inflect 2018 announces Innoplexus AG as a 2018 TiE50 Finalist
April 23, 2018 – Eschborn – Innoplexus AG is excited to announce that it has been selected as a “2018 TiE50 Finalist” for the prestigious TiE50 Awards Program recognizing the world’s most innovative tech startups. This awards competition is part of TiE Inflect 2018, the world’s largest conference for tech entrepreneurs.Read More